XEN Glaucoma Gel Stent Versus Trabeculectomy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

XEN Glaucoma Gel Stent Versus Trabeculectomy — Stella

Home/Primary Open Angle Glaucoma/

View on ClinicalTrials.gov

Recruiting

Back to Primary Open Angle Glaucoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Austria

Dept. Ophthalmology and Optometry Paracelsus Medical University, Salzburg

Key details

Sponsor

Prof. Dr. Herbert Reitsamer

Enrollment target

~196 participants

Started

December 2023

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.